Pulseless electrical activity (PEA) is a type of cardiac arrest characterized by organized electrical activity on an electrocardiogram (ECG) despite the absence of a measurable pulse. It occurs when the heart's electrical system fires normally, but mechanical contraction fails due to underlying physiological dysfunction.
PEA accounts for approximately 15-20% of out-of-hospital cardiac arrests and is often associated with reversible causes such as hypovolemia, tension pneumothorax, myocardial infarction, or severe hypoxia. Unlike ventricular fibrillation or pulseless ventricular tachycardia, PEA does not respond to defibrillation because the issue lies not in the heart's rhythm but in its ability to translate electrical signals into effective contractions.
According to the American Heart Association (AHA), PEA is diagnosed when a patient shows organized ECG activity-typically sinus rhythm, atrial fibrillation, or other non-shockable rhythms-but lacks a palpable pulse. The AHA emphasizes that immediate recognition and treatment of reversible causes are essential, as survival rates remain low without timely intervention.
The heart relies on coordinated electrical impulses to trigger synchronized muscle contractions. In PEA, the electrical system functions properly, but the mechanical response fails. This disconnect can result from inadequate cardiac output due to volume depletion, impaired contractility, or vascular obstruction.
For example, a patient with massive internal bleeding may have a normal ECG pattern but no detectable blood pressure or pulse. The heart continues to generate electrical signals, but the volume of blood in the circulatory system is too low to sustain perfusion. Without rapid fluid resuscitation or surgical control of hemorrhage, organ failure rapidly follows.
A 2021 study published in Circulation found that patients presenting with PEA had a 12% survival-to-discharge rate when treated within six minutes of collapse, compared to 3% when treatment was delayed beyond ten minutes. This underscores the urgency of identifying PEA early and acting on its underlying causes.
PEA is not a single disease but a clinical syndrome resulting from multiple pathophysiological states. The most common reversible causes are summarized below:
| Reversible Cause | Prevalence in PEA Cases | Key Diagnostic Clue |
|---|---|---|
| Hypovolemia (low blood volume) | 25% | History of trauma, dehydration, or gastrointestinal bleeding |
| Tension pneumothorax | 15% | Tracheal deviation, absent breath sounds on one side, distended neck veins |
| Myocardial infarction (heart attack) | 10% | Elevated troponin, ST-segment changes on ECG |
| Hypoxia | 12% | Respiratory distress, low oxygen saturation, airway obstruction |
| Hyperkalemia or acidosis | 8% | Electrolyte abnormalities on lab tests, ECG changes like peaked T waves |
These conditions are grouped under the mnemonic "Hs and Ts" used in advanced cardiac life support (ACLS) protocols. The "Hs" include hypovolemia, hypoxia, hydrogen ion (acidosis), hyperkalemia/hypokalemia, hypothermia, and hypo/hyperglycemia. The "Ts" cover tamponade (cardiac), thrombosis (coronary or pulmonary), toxins, and tension pneumothorax.
PEA is not a primary arrhythmia. It is a secondary phenomenon triggered by systemic failure. Misdiagnosing PEA as a shockable rhythm leads to inappropriate defibrillation, which wastes time and reduces survival chances.
PEA is frequently mistaken for ventricular fibrillation (VF) or pulseless ventricular tachycardia (VT). Both VF and VT show chaotic or rapid rhythms on ECG and are treatable with defibrillation. PEA, however, shows organized waveforms-often resembling sinus rhythm-and requires different interventions.
A common error among providers is assuming that any organized ECG pattern equates to a viable rhythm. In reality, a patient with sinus rhythm and no pulse still meets criteria for PEA. One study in Resuscitation reported that 37% of PEA cases were initially misclassified as shockable rhythms during emergency department resuscitations, leading to delayed treatment of the root cause.
Another misconception is that PEA is always fatal. While outcomes are poor, survival is possible with prompt identification and treatment of reversible factors. A 2020 retrospective analysis of 1,200 cardiac arrest cases in the National Registry of Cardiopulmonary Resuscitation (NRCPR) showed that 16% of PEA patients survived to hospital discharge when treated with targeted therapies, including vasopressors and fluid resuscitation.
In a documented case from a Level I trauma center, a 34-year-old male arrived after a motor vehicle collision with a systolic blood pressure of 70 mmHg and no palpable pulse. His ECG showed sinus tachycardia at 130 bpm with normal morphology. He was unresponsive and not breathing adequately.
Emergency medical services initiated rapid transport and fluid resuscitation. Upon arrival, the team confirmed PEA via ECG and began ACLS protocols. Ultrasound revealed free fluid in the abdomen-indicating internal bleeding. The patient underwent emergent laparotomy, where a ruptured spleen was identified and repaired.
After 45 minutes of aggressive resuscitation, including epinephrine and packed red blood cell transfusions, the patient regained a pulse and was stabilized. He was discharged home after three weeks in the ICU. This case illustrates that PEA is not a terminal diagnosis-it is a warning sign requiring immediate investigation and treatment of underlying pathology.
I once witnessed a paramedic team respond to a call for a collapsed man in his 50s. On arrival, he was pulseless and apneic. The ECG monitor displayed a regular sinus rhythm at 90 beats per minute. The team correctly identified this as PEA and initiated high-quality CPR and vasopressor administration.
They performed a focused assessment with sonography for trauma (FAST) exam and detected a large amount of fluid in the peritoneal cavity. The patient was rushed to surgery, where a perforated bowel was found and repaired. He survived and was discharged to rehab. That event reinforced that PEA demands a systems-based approach-not just medication, but rapid diagnostics and teamwork.
Under ICD-10 coding, PEA is classified under code Z51.89 (Encounter for other specified reasons) when used as a principal diagnosis. However, the specific etiology must be documented separately. For example, if PEA results from sepsis, the correct codes are A41.9 (unspecified sepsis) and R57.9 (shock, unspecified).
Accurate coding ensures proper billing, research tracking, and quality improvement. According to the Centers for Medicare & Medicaid Services (CMS), incorrect assignment of cardiac arrest codes leads to 18% higher denial rates in hospital claims. Providers must document the presence of electrical activity without a pulse to justify PEA coding.
PEA is not synonymous with "flatline." A flatline ECG indicates asystole-a complete absence of electrical activity. Asystole is managed differently: it requires immediate CPR and epinephrine, not the search for reversible causes that defines PEA management.
PEA is not a standalone diagnosis. It is a clinical state that points to an underlying problem. Treating PEA effectively means treating the cause-whether it's hemorrhage, pulmonary embolism, or drug overdose. Focusing solely on the ECG pattern without considering physiology leads to poor outcomes.
Understanding what is pea in cardiac arrest means recognizing that the heart may be "electrical" but not "functional." The key is not to fix the rhythm-but to fix the system that failed to deliver blood.